However, the Hispanic AML population from PR has significantly higher mutation rates in WT1 and KRAS genes than the Bradley cohort and a significantly lower mutation rate in the ASXL1 gene than the Darbinyan cohort. The gene discussed is WT1; the disease is acute myeloid leukemia.